Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b-245 alpha chain (CYBA, commonly known as p22phox) is a 22 kDa integral membrane protein forming part of the NADPH oxidase complex, where it heterodimerizes with the beta chain (NOX2/gp91phox) to form cytochrome b-245, the core enzyme for superoxide production in phagocytes. Upon activation by pathogens, NADPH oxidase assembles at the plasma or phagosomal membrane and initiates electron transfer from cytosolic NADPH, via FAD and heme moieties, to molecular oxygen—generating superoxide, a critical component of the microbicidal respiratory burst. CYBA is also expressed in endothelial and smooth muscle cells, where it partners with other NOX proteins (NOX1, NOX3, NOX4) to regulate reactive oxygen species in vascular biology. Genetic mutations in CYBA result in a rare form of chronic granulomatous disease due to defective superoxide generation, and specific polymorphisms have been linked to decreased oxidative stress and risk of cardiovascular disease. CYBA and NADPH oxidase are research targets for inhibitors in cardiovascular, inflammatory, and infectious pathologies, but safety concerns limit clinical translation.
Inhibition of NADPH oxidase assembly and/or electron transfer, leading to decreased production of superoxide and downstream reactive oxygen species; Blocking p22phox interaction impairs electron flow from NADPH to oxygen
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b-245 alpha chain (CYBA).